Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value

$4.97−0.07 (-1.39%)

Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%

Lifevantage EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Lifevantage's EV/EBITDA was 5.0× on Nov 11, 2026, against 5.0× a year earlier. Over the last 5 years it ranged from 1.8× to 26.0×, with a median of 6.8×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	5.0×	+0.6
2025	Dec 31, 2025	4.4×	−16.9
2024	Dec 31, 2024	21.2×	+13.4
2023	Dec 29, 2023	7.8×	+4.0
2022	Dec 30, 2022	3.8×	+0.9
2021	Dec 31, 2021	2.9×	−2.9
2020	Dec 31, 2020	5.8×	−10.0
2019	Dec 31, 2019	15.9×	+1.0
2018	Dec 31, 2018	14.9×	+3.4
2017	Dec 29, 2017	11.5×	+3.7
2016	Dec 30, 2016	7.8×	−4.5
2015	Dec 31, 2015	12.3×	+6.7
2014	Dec 31, 2014	5.7×	−8.6
2013	Dec 31, 2013	14.3×	+5.6
2012	Dec 31, 2012	8.7×	−10.1
2011	Dec 30, 2011	18.8×	–